Indivior Pharmaceuticals, Inc. INDV Deferred Taxes
Deferred Taxes at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's deferred taxes?
- Indivior Pharmaceuticals, Inc. (INDV) reported deferred taxes of $27M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's deferred taxes changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's deferred taxes increased by 1450.0% year-over-year, from -$2M to $27M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's deferred taxes?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's deferred taxes has grown at a -23.8% compound annual growth rate (CAGR), from -$104M to -$46M.
- What does deferred taxes mean?
- Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.